Karen A. Bostian

802 total citations
20 papers, 700 citations indexed

About

Karen A. Bostian is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Karen A. Bostian has authored 20 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Neurology and 3 papers in Oncology. Recurrent topics in Karen A. Bostian's work include Analytical chemistry methods development (3 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Karen A. Bostian is often cited by papers focused on Analytical chemistry methods development (3 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Karen A. Bostian collaborates with scholars based in United States and United Kingdom. Karen A. Bostian's co-authors include James J. Schmidt, Robert G. Stafford, William R. Beisel, W. R. Beisel, Robert S. Pekarek, Thomas W. Geisbert, Judith G. Pace, George A. Miura, John D. White and Nancy Robinson and has published in prestigious journals such as Biochemical Journal, FEBS Letters and Infection and Immunity.

In The Last Decade

Karen A. Bostian

20 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen A. Bostian United States 12 278 257 93 84 82 20 700
Paul C. Rumsby United Kingdom 17 514 1.8× 159 0.6× 124 1.3× 26 0.3× 83 1.0× 39 1.2k
Hirofumi Goto Japan 13 126 0.5× 106 0.4× 43 0.5× 29 0.3× 8 0.1× 50 615
Félix V. Vega Spain 17 488 1.8× 16 0.1× 40 0.4× 61 0.7× 75 0.9× 26 1.1k
Paula J. Lapinskas United States 10 435 1.6× 34 0.1× 21 0.2× 133 1.6× 87 1.1× 11 851
Jan Czerniecki Poland 14 129 0.5× 252 1.0× 10 0.1× 56 0.7× 21 0.3× 34 715
Isaac Mohar United States 15 443 1.6× 17 0.1× 37 0.4× 57 0.7× 36 0.4× 22 1.1k
J.P. Carreau France 11 237 0.9× 31 0.1× 10 0.1× 185 2.2× 38 0.5× 41 786
Per Eric Lindahl Sweden 14 258 0.9× 17 0.1× 29 0.3× 15 0.2× 41 0.5× 52 700
Dorsey T. Mahin United States 7 175 0.6× 16 0.1× 19 0.2× 29 0.3× 36 0.4× 8 537
Agathe Tarze France 11 357 1.3× 17 0.1× 22 0.2× 130 1.5× 67 0.8× 14 648

Countries citing papers authored by Karen A. Bostian

Since Specialization
Citations

This map shows the geographic impact of Karen A. Bostian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen A. Bostian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen A. Bostian more than expected).

Fields of papers citing papers by Karen A. Bostian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen A. Bostian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen A. Bostian. The network helps show where Karen A. Bostian may publish in the future.

Co-authorship network of co-authors of Karen A. Bostian

This figure shows the co-authorship network connecting the top 25 collaborators of Karen A. Bostian. A scholar is included among the top collaborators of Karen A. Bostian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen A. Bostian. Karen A. Bostian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, James J., Robert G. Stafford, & Karen A. Bostian. (1998). Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1′ binding subsite. FEBS Letters. 435(1). 61–64. 71 indexed citations
2.
Schmidt, James J. & Karen A. Bostian. (1997). Endoproteinase Activity of Type A Botulinum Neurotoxin: Substrate Requirements and Activation by Serum Albumin. Journal of Protein Chemistry. 16(1). 19–26. 108 indexed citations
3.
Schmidt, James J. & Karen A. Bostian. (1995). Proteolysis of synthetic peptides by type A botulinum neurotoxin. Journal of Protein Chemistry. 14(8). 703–708. 102 indexed citations
4.
Major, Michael A., David H. Rosenblatt, & Karen A. Bostian. (1991). The octanol/water partition coefficient of methylmercuric chloride and methylmercuric hydroxide in pure water and salt solutions. Environmental Toxicology and Chemistry. 10(1). 5–8. 31 indexed citations
5.
Major, Michael A., David H. Rosenblatt, & Karen A. Bostian. (1991). THE OCTANOL/WATER PARTITION COEFFICIENT OF METHYLMERCURIC CHLORIDE AND METHYLMERCURIC HYDROXIDE IN PURE WATER AND SALT SOLUTIONS. Environmental Toxicology and Chemistry. 10(1). 5–5. 1 indexed citations
6.
Miura, George A., Nancy Robinson, Thomas W. Geisbert, et al.. (1989). Comparison of in vivo and in vitro toxic effects of microcystin-LR in fasted rats. Toxicon. 27(11). 1229–1240. 85 indexed citations
8.
Canonico, P G, et al.. (1980). Elevated glycosyltransferase activities in infected or traumatized hosts: nonspecific response to inflammation. Infection and Immunity. 29(1). 114–118. 6 indexed citations
9.
Powanda, Michael C., et al.. (1979). Differential effect of clofibrate on inflammation-induced alterations in plasma proteins in the rat. Biochemical Journal. 178(3). 633–641. 7 indexed citations
10.
Bostian, Karen A., et al.. (1979). Kinetic and spectroscopic evidence of cation-induced conformation changes in yeast K+-activated aldehyde dehydrogenase. Biochemical Journal. 183(3). 633–646. 8 indexed citations
11.
Bostian, Karen A., et al.. (1978). Kinetics and reaction mechanism of potassium-activated aldehyde dehydrogenase from Saccharomyces cerevisiae. Biochemical Journal. 173(3). 787–798. 31 indexed citations
12.
Wannemacher, Robert W., et al.. (1978). Protein‐Sparing Therapy During Pneumococcal infection in Rhesus Monkeys. Journal of Parenteral and Enteral Nutrition. 2(4). 507–518. 11 indexed citations
13.
Bostian, Karen A., et al.. (1978). Rapid purification and properties of potassium-activated aldehyde dehydrogenase from Saccharomyces cerevisiae. Biochemical Journal. 173(3). 773–786. 59 indexed citations
14.
Powanda, Michael C., et al.. (1978). Clofibrate-induced alterations in zinc, iron and copper metabolism. Biochemical Pharmacology. 27(1). 125–127. 6 indexed citations
15.
Bostian, Karen A., et al.. (1976). Sequential changes in the concentration of specific serum proteins during typhoid fever infection in man.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 87(4). 577–85. 34 indexed citations
16.
Pekarek, Robert S., Herbert L. DuPont, Robert W. Wannemacher, et al.. (1975). Serum Zinc, Iron, and Copper Concentrations during Typhoid Fever in Man: Effect of Chloramphenicol Therapy. Clinical Chemistry. 21(4). 528–532. 13 indexed citations
17.
Bostian, Karen A., et al.. (1975). Thallium activation and inhibition of yeast aldehyde dehydrogenase. FEBS Letters. 59(1). 88–91. 7 indexed citations
18.
Pekarek, Robert S., William R. Beisel, Peter J. Bartelloni, & Karen A. Bostian. (1972). Determination of Serum Zinc Concentrations in Normal Adult Subjects by Atomic Absorption Spectrophotometry. American Journal of Clinical Pathology. 57(4). 506–510. 53 indexed citations
19.
Squibb, Robert L., W. R. Beisel, & Karen A. Bostian. (1971). Effect of Newcastle Disease on Serum Copper, Zinc, Cholesterol, and Carotenoid Values in the Chick. Applied Microbiology. 22(6). 1096–1099. 13 indexed citations
20.
Pekarek, R. S., Karen A. Bostian, P. J. Bartelloni, Frank M. Calia, & W. R. Beisel. (1969). The Effects of Francisella Tularensis Infection on Iron Metabolism in Man. The American Journal of the Medical Sciences. 258(1). 14–25. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026